CELLECTIS
Patent Owner
Stats
- 29 US PATENTS IN FORCE
- 29 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 29 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,523 Total Citation Count
- Dec 30, 1987 Earliest Filing
- 70 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0296,623 INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR OR N-CAR) EXPRESSING NON-T CELL TRANSDUCTION DOMAINDec 17, 15Oct 19, 17[A61K, C07K]
2017/0283,497 ROR1 (NTRKR1) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPYJul 29, 15Oct 05, 17[A61K, C12N, C07K]
2017/0275,374 TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPYSep 03, 15Sep 28, 17[C12N, C07K]
2017/0260,513 TEVI CHIMERIC ENDONUCLEASE AND THEIR PREFERENTIAL CLEAVAGE SITESMar 22, 17Sep 14, 17[C12N, C07K]
2017/0081,672 MODIFYING MESSENGER RNA STABILITY IN PLANT TRANSFORMATIONSFeb 29, 16Mar 23, 17[C12N, A01H]
2017/0035,866 METHOD FOR GENERATING IMMUNE CELLS RESISTANT TO ARGININE AND/OR TRYPTOPHAN DEPLETED MICROENVIRONMENTApr 10, 15Feb 09, 17[A61K, C12N, C07K]
2017/0016,025 METHOD FOR GENERATING T-CELLS COMPATIBLE FOR ALLOGENIC TRANSPLANTATIONMar 11, 15Jan 19, 17[C12N, C07K]
2016/0361,359 METHOD OF ENGINEERING CHEMOTHERAPY DRUG RESISTANT T-CELLS FOR IMMUNOTHERAPYNov 21, 14Dec 15, 16[A61K, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9890393 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease systemApr 01, 14Feb 13, 18[C12N]
9855297 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease systemFeb 17, 16Jan 02, 18[A61K, C12N]
9540623 Method for increasing the efficiency of double-strand-break induced mutagenesisJul 03, 12Jan 10, 17[C12N]
9315788 Method for the generation of compact TALE-nucleases and uses thereofApr 05, 12Apr 19, 16[C12N, C07K]
9290748 Use of endonucleases for inserting transgenes into safe harbor lociFeb 28, 11Mar 22, 16[A61K, C12Q, C12N]
9273296 Meganuclease variants cleaving a DNA target sequence from a glutamine synthetase gene and uses thereofSep 08, 08Mar 01, 16[C12N]
9044492 Method for modulating the efficiency of double-strand break-induced mutagenesisFeb 06, 12Jun 02, 15[A61K, C12Q, C12N]
8979818 Method and apparatus for the delivery of polynucleotide vaccines to mammalian skinMar 15, 11Mar 17, 15[A61K, A61N, C07K, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0198,306 ENGINEERING MAMMALIAN GENOME USING DNA-GUIDED ARGONAUTE INTERFERENCE SYSTEMS (DAIS)AbandonedMar 23, 15Jul 13, 17[C12N]
2015/0376,585 TEVI CHIMERIC ENDONUCLEASE AND THEIR PREFERENTIAL CLEAVAGE SITESAbandonedJan 29, 14Dec 31, 15[C12N, C07K]
2015/0315,557 MEGANUCLEASE VARIANTS CLEAVING THE GENOME OF A PATHOGENIC NON-INTEGRATING VIRUS AND USES THEREOFAbandonedJun 19, 15Nov 05, 15[C12N]
2015/0017,136 METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPYAbandonedJul 15, 13Jan 15, 15[A61K]
2014/0230,083 MODULAR BASE-SPECIFIC NUCLEIC ACID BINDING DOMAINS FROM BURKHOLDERIA RHIZOXINICA PROTEINSAbandonedJul 24, 13Aug 14, 14[C12N, A01K]
2014/0178,561 POTATOES WITH REDUCED COLD-INDUCED SWEETENINGAbandonedDec 20, 13Jun 26, 14[A23L, C12N]
2014/0178,942 MEGANUCLEASE VARIANTS CLEAVING AT LEAST ONE TARGET IN THE GENOME OF A RETROVIRUS AND USES THEREOFAbandonedOct 28, 13Jun 26, 14[C12P]
2014/0112,904 METHOD FOR ENHANCING THE CLEAVAGE ACTIVITY OF I-CREI DERIVED MEGANUCLEASESAbandonedJun 06, 08Apr 24, 14[A01P, A61K, C07H, A01N, C12N, A01K, A01H, A61P]
2014/0038,239 MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HUMAN HEMOGLOBIN BETA GENE AND USES THEREOFAbandonedJun 04, 13Feb 06, 14[C12P]
2014/0017,731 MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HUMAN INTERLEUKIN-2 RECEPTOR GAMMA CHAIN GENE AND USES THEREOFAbandonedMay 29, 13Jan 16, 14[C12P]
2013/0326,644 LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING MUTATIONS IN TWO FUNCTIONAL SUBDOMAINS AND USE THEREOFAbandonedJun 13, 13Dec 05, 13[C12N]
2013/0236,946 MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE MOUSE ROSA26 LOCUS AND USES THEREOFAbandonedApr 05, 13Sep 12, 13[C12N]
2013/0227,715 USE OF ENDONUCLEASES FOR INSERTING TRANSGENES INTO SAFE HARBOR LOCIAbandonedFeb 28, 11Aug 29, 13[C12N]
2013/0209,437 I-CREI HOMING ENDONUCLEASE VARIANTS HAVING NOVEL CLEAVAGE SPECIFICITY AND USE THEREOFAbandonedJan 17, 13Aug 15, 13[A01N, C12N]
2013/0203,840 USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOFAbandonedOct 10, 12Aug 08, 13[A61K]
2013/0196,320 METHOD FOR IMPROVING CLEAVAGE OF DNA BY ENDONUCLEASE SENSITIVE TO METHYLATIONAbandonedJun 15, 11Aug 01, 13[C12P]
2013/0189,759 MEGANUCLEASES VARIANTS CLEAVING A DNA TARGET SEQUENCE IN THE NANOG GENE AND USES THEREOFAbandonedJul 07, 11Jul 25, 13[C12N]
2013/0183,282 Meganuclease variants cleaving a DNA target sequence from the rhodopsin gene and uses thereofAbandonedMay 12, 11Jul 18, 13[C12N]
2013/0149,786 I-CREI VARIANTS WITH NEW SPECIFICITY AND METHODS OF THEIR GENERATIONAbandonedApr 30, 10Jun 13, 13[C12N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.